Predictive value of lung function trend and FeNO for difficult asthma in children

Journal of Investigational Allergology and Clinical Immunology

Volumn 22, Issue 6, 2012, Pages 419-426

  Agache, Ioana ^a   Ciobanu, C ^b  

^a TRANSILVANIA UNIVERSITY OF BRASOV   (Romania)

^b Department of Allergy and Clinical Immunology   (Romania)

Author keywords

Asthma; Disease exacerbation; Inflammation; Lung function tests; Risk factors

Indexed keywords

BUDESONIDE; CICLESONIDE; CORTICOSTEROID; FLUTICASONE; NITRIC OXIDE;

AIRWAY OBSTRUCTION; ARTICLE; ASTHMA; ATOPY; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE DURATION; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG TREATMENT FAILURE; FEMALE; FORCED EXPIRATORY VOLUME; FRACTION OF EXHALED NITRIC OXIDE; GENDER; HUMAN; LUNG FUNCTION TEST; MALE; MENTAL DISEASE; OBESITY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PHENOTYPE; PREDICTIVE VALUE; PROSPECTIVE STUDY; RESPIRATORY TRACT PARAMETERS; RHINITIS; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; SOCIAL STATUS; TOBACCO; TREND STUDY;

ADMINISTRATION, INHALATION; ADOLESCENT; ADRENAL CORTEX HORMONES; ADRENERGIC BETA-2 RECEPTOR AGONISTS; ASTHMA; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INDIVIDUALIZED MEDICINE; MALE; NITRIC OXIDE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RECURRENCE; RESPIRATORY FUNCTION TESTS; RISK FACTORS;

EID: 84868008174     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Fleming L, Wilson N, Bush A. Diffi cult to control asthma in children. Curr Opin Allergy Clin Immunol. 2007;7:190-205.
2. Bush A, Menzies-Gow A. Phenotypic differences between pediatric and adult asthma. Proc Am Thorac Soc. 2009;6:712-19.
3. Hedlin G, Bush A, Lødrup Carlsen K, Wennergren G, De Benedictis FM, Melén E, Paton J, Wilson N, Carlsen KH. Problematic Severe Asthma in Childhood Initiative group. Problematic severe asthma in children, not one problem but many: a GA2LEN initiative. Eur Respir J. 2010; 36:196-201.
4. Lødrup Carlsen KC, Hedlin G, Bush A, Wennergren G, de Benedictis FM, De Jongste JC, Baraldi E, Pedroletti C, Barbato A, Malmström K, Pohunek P, Pedersen S, Piacentini GL, Middelveld RJ, Carlsen KH; PSACI (Problematic Severe Asthma in Childhood Initiative) group. Assessment of problematic severe asthma in children. Eur Respir J. 2011;37:432-40.
5. Bush A, Saglani S. Management of severe asthma in children. Lancet. 2010;376:814-25.
6. Lang A, Mowinckel P, Sachs-Olsen C, Riiser A, Lunde J, Carlsen KH, Carlsen KC. Asthma severity in childhood, untangling clinical phenotypes. Pediatr Allergy Immunol. 2010;21:945-53.
7. Huikuri HV, Perkiömäki JS, Maestri R, Pinna GD. Clinical impact of evaluation of cardiovascular control by novel methods of heart rate dynamics. Philos Transact A Math Phys Eng Sci. 2009;367:1223-38.
8. Peng CK, Havlin S, Stanley HE, Goldberger AL. Quantifi cation of scaling exponents and crossover phenomena in non-stationary heartbeat time series. Chaos. 1995;5:82-7.
9. Celli A, Gratton E. Dynamics of lipid domain formation: fl uctuation analysis. Biochim Biophys Acta. 2010;1798:1368-76.
10. Taylor DR, Town GI, Herbison GP, Boothman-Burrell D, Flannery EM, Hancox B, Harré E, Laubscher K, Linscott V, Ramsay CM, Richards G. Asthma control during long term treatment with regular inhaled salbutamol and salmeterol. Thorax. 1998;53:744-52.
11. Frey U, Brodbeck T, Majumdar A, Taylor DR, Town GI, Silverman M, Suki B. Risk of severe asthma episodes predicted from fl uctuation analysis of airway function. Nature. 2005;438:667-70.
12. Thamrin C, Stern G, Strippoli MP, Kuehni CE, Suki B, Taylor DR, Frey U. Fluctuation analysis of lung function as a predictor of long-term response to beta 2-agonists. Eur Respir J. 2009;33:486-93.
13. Lee JH, Haselkorn T, Borish L, Rasouliyan L, Chipps BE, Wenzel SE. Risk Factors Associated With Persistent Airfl ow Limitation in Severe or Diffi cult-to-Treat Asthma: Insights From the TENOR Study. Chest. 2007;132:1882-9.
14. ten Brinke A, Zwinderman AH, Sterk PJ, Rabe KF, Bel EH. Factors Associated with Persistent Airfl ow Limitation in Severe Asthma. Am J Respir Crit Care Med. 2001;164:744-8.
15. Barnes PJ, Dweik RA, Gelb AF, Gibson PG, George SC, Grasemann H, Pavord ID, Ratjen F, Silkoff PE, Taylor DR, Zamel 425 N. Exhaled nitric oxide in pulmonary diseases: a comprehensive review. Chest. 2010;138:682-92.
16. Debley JS, Stamey DC, Cochrane ES, Gama KL, Redding GJ. Exhaled nitric oxide, lung function, and exacerbations in wheezy infants and toddlers. J Allergy Clin Immunol. 2010;125:1228-34.
17. Islam T, Breton C, Salam MT, McConnell R, Wenten M, Gauderman WJ, Conti D, Van Den Berg D, Peters JM, Gilliland FD. Role of inducible nitric oxide synthase in asthma risk and lung function growth during adolescence. Thorax. 2010;65:139-45.
18. Bastain TM, Islam T, Berhane KT, McConnell RS, Rappaport EB, Salam MT, Linn WS, Avol EL, Zhang Y, Gilliland FD. Exhaled nitric oxide, susceptibility and new-onset asthma in the children's health study. Eur Respir J. 2011;37:523-31.
19. Kercsmar C. Exhaled nitric oxide in the diagnosis and management of childhood asthma. Ther Adv Respir Dis. 2010;4:71-82.
20. Van Dixhoorn J, Duivenvoorden HJ. Effi cacy of Nijmegen questionnaire in recognition of the hyperventilation syndrome. J Psychosom Res. 1985;29:199-206.
21. Shaffer D, Fisher P, Dulcan MK, Davies M, Piacentini J, Schwab-Stone ME, Lahey BB, Bourdon K, Jensen PS, Bird HR, Canino G, Regier DA. The NIMH Diagnostic Interview Schedule for Children Version 2.3 (DISC-2.3): description, acceptability, prevalence rates, and performance in the MECA Study. Methods for the Epidemiology of Child and Adolescent Mental Disorders Study. J Am Acad Child Adolesc Psychiatry. 1996; 35:865-77.
22. Shaffer D, Fisher P, Lucas CP, Dulcan MK, Schwab-Stone ME. NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISC-IV): description, differences from previous versions, and reliability of some common diagnoses. J Am Acad Child Adolesc Psychiatry. 2000;39:28-38.
23. Dressel H, de la Motte D, Reichert J, Ochmann U, Petru R, Angerer P, Holz O, Nowak D, Jörres RA. Exhaled nitric oxide: Independent effects of atopy, smoking, respiratory tract infection, gender and height. Respir Med. 2008;102:962-9.
24. Valero A, Ferrer M, Sastre J, Navarro AM, Monclus L, Marti-Guadano E et al. A new criterion by which to discriminate between patients with moderate allergic rhinitis and patients with severe allergic rhinitis based on the Allergic Rhinitis and its Impact on Asthma severity items. J Allergy Clin Immunol. 2007;120:359-65.
25. Sharma S, Litonjua AA, Tantisira KG, Fuhlbrigge AL, Szefl er SJ, Strunk RC, Zeiger RS, Murphy AJ, Weiss ST; Childhood Asthma Management Program Research Group. Clinical predictors and outcomes of consistent bronchodilator response in the childhood asthma management program. J Allergy Clin Immunol. 2008 Nov;122(5):921-8.
26. Covar RA, Strunk R, Zeiger RS, Wilson LA, Liu AH, Weiss S, Tonascia J, Spahn JD, Szefl er SJ; Childhood Asthma Management Program Research Group. Predictors of remitting, periodic, and persistent childhood asthma. J Allergy Clin Immunol. 2010;125(2):359-66
27. Konradsen JR, Nordlund B, Lidegran M, Pedroletti C, Grönlund H, van Hage M, Dahlen B, Hedlin G; Swedish Network of Pediatric Allergists, Severe Asthma Network. Problematic severe asthma: a proposed approach to identifying children who are severely resistant to therapy. Pediatr Allergy Immunol. 2011;22:9-18.
28. Matricardi PM, Grüber C, Wahn U, Lau S. The asthma-obesity link in childhood: open questions, complex evidence, a few answers only. Clin Exp Allergy. 2007;37:476-84.
29. Michelson PH, Williams LW, Benjamin DK, Barnato AE. Obesity, infl ammation, and asthma severity in childhood: data from the National Health and Nutrition Examination Survey 2001-2004. Ann Allergy Asthma Immunol. 2009;103:381-5.
30. Kattan M, Kumar R, Bloomberg GR, Mitchell HE, Calatroni A, Gergen PJ, Kercsmar CM, Visness CM, Matsui EC, Steinbach SF, Szefl er SJ, Sorkness CA, Morgan WJ, Teach SJ, Gan VN. Asthma control, adiposity, and adipokines among inner-city adolescents. J Allergy Clin Immunol. 2010;125:584-92.
31. Haselkorn T, Szefl er SJ, Simons FE, Zeiger RS, Mink DR, Chipps BE, Borish L, Wong DA; TENOR Study Group. Allergy, total serum immunoglobulin E, and airfl ow in children and adolescents in TENOR. Pediatr Allergy Immunol. 2010;21:1157-65.
32. van Veen IH, Ten Brinke A, Sterk PJ, Sont JK, Gauw SA, Rabe KF, Bel EH. Exhaled nitric oxide predicts lung function decline in diffi cult-to-treat asthma. Eur Respir J. 2008;32:344-9.
33. Kostikas K, Papaioannou AI, Tanou K, Giouleka P, Koutsokera A, Minas M, Papiris S, Gourgoulianis KI, Taylor DR, Loukides S. Exhaled NO and exhaled breath condensate pH in the evaluation of asthma control. Respir Med. 2011;105:526-32.
34. Ghdifan S, Verin E, Couderc L, Lubrano M, Michelet I, Marguet C. Exhaled nitric oxide fractions are well correlated with clinical control in recurrent infantile wheeze treated with inhaled corticosteroids. Pediatr Allergy Immunol. 2010;21:1015-20.
35. Schneider A, Tilemann L, Schermer T, Gindner L, Laux G, Szecsenyi J, Meyer FJ. Diagnosing asthma in general practice with portable exhaled nitric oxide measurement--results of a prospective diagnostic study: FENO < or = 16 ppb better than FENO < or =12 ppb to rule out mild and moderate to severe asthma. Respir Res. 2009, 10: 15 doi:10.1186/1465-9921-10-15.
36. Bacharier LB, Strunk RC, Mauger D, White D, Lemanske RF Jr, Sorkness CA. Classifying asthma severity in children: mismatch between symptoms, medication use, and lung function. Am J Respir Crit Care Med. 2004;170:426-32.
37. Bacharier LB, Guilbert TW, Zeiger RS, Strunk RC, Morgan WJ, Lemanske RF Jr, Moss M, Szefl er SJ, Krawiec M, Boehmer S, Mauger D, Taussig LM, Martinez FD; Childhood Asthma Research and Education Network of the National Heart, Lung, and Blood Institute. Patient characteristics associated with improved outcomes with use of an inhaled corticosteroid in preschool children at risk for asthma. J Allergy Clin Immunol. 2009;123:1077-82.
38. Lex C, Payne DN, Zacharasiewicz A, Li AM, Nicholson AG, Wilson NM, Bush A. Is a two-week trial of oral prednisolone predictive of target lung function in pediatric asthma? Pediatr Pulmonol. 2005;39:521-27.